An open safety study with the monoaminergic stabilizer (-)-OSU6162 in patients with mental fatigue and related vitality and wakefulness disturbances associated with neurologiacal disorders, e g Parkinson’s disease, Huntington’s disease, brain trauma, stroke, myalgic encephalomyelitis and narcolepsy. An open safety study with the monoaminergic stabilizer (-)-OSU6162 in patients with mental fatigue a ...
An open safety study with the monoaminergic stabilizer (-)-OSU6162 in patients with mental fatigue and related vitality and wakefulness disturbances associated with neurologiacal disorders, e g Parkinson’s disease, Huntington’s disease, brain trauma, stroke, myalgic encephalomyelitis and narcolepsy. - OSU6162Open1309 An open safety study with the monoaminergic stabilizer (-)-OSU6162 in patients with mental fatigue a ...
TREATMENT OF DYSKINESIAS IN PARKINSON’S DISEASE WITH OSU6162 – A PILOT STUDY
TREATMENT OF DYSKINESIAS IN PARKINSON’S DISEASE WITH OSU6162 – A PILOT STUDY
Parkinsons disease is complicated by dyskinesias and dystonia. Due stabilizing properties, we believe (-)-OSU6162 may alleviate dyskinesias, without causing parkinsonism. Aim: To evaluate in a double-blind cross over pilot study whether OSU6162 attenuates dyskinesias without worsening parkinsonism in PD patients with motor complications using clinical examination and patient diaries. Parkinsons disease is complicated by dyskinesias and dystonia. Due stabilizing properties, we believ ...
Product Name: not available Product Code: OSU6162similarto(-)-OSU6162 INN or Proposed INN: not available Product Name: not available Product Code: OSU6162similarto(-)-OSU6162 INN or Proposed INN: not av ...